Deadly assaults across the French capital have sparked the sort of international solidarity which could help Europe surmount recent acrimony over issues such as migration. But the fears they generate may shape debates about security and cultural integration in ways that divide.
Breakingviews
Heads won’t roll at Mylan despite blunders
Rather than take a $40 bln-plus offer from Teva, the drug firm pursued Perrigo, whose owners rejected the bid on Friday. The vote was partly against Mylan’s poor governance – which also makes it unusually hard for its own shareholders to turf out inept executives and directors.
Hulu deal would broadcast mixed signal
Time Warner may buy into the U.S. video-streaming service already backed by Comcast, Disney and Fox. Though the implied value is bound to be far less, Hulu could be worth some $17 bln, according to Breakingviews calculations. The ownership structure warrants a big discount.
China catalyst could spark Syngenta chain reaction
The Swiss pesticides group has rejected a $42 bln bid approach from China National Chemical Corp, reports say. Interest from rival Monsanto was rebuffed earlier this year, and last month the Syngenta CEO stepped down. It looks vulnerable to a round of chemical re-engineering.
Barcelona at risk of being the Montreal of Spain
The uncertainties surrounding regional separatism contributed to the economic problems of Canada’s second city. The tensions of Catalonian nationalism could also harm its capital city. There’s no clear evidence of exodus yet, but Catalan politicians would be foolish to ignore the risk.
Cerberus finds workaround for Northern Rock mess
The private equity firm is paying a premium for 13 bln stg of assets from the collapsed UK lender. It helps the state’s finances, but leaves Cerberus to fund a big portfolio itself. Selling a 3 bln stg chunk to TSB, and better securitisation markets, suggest a way to do so.
Investors in China haunted by “key man” clause
Creditors to mainland companies sometimes insist on repayment if a top executive leaves. The provision looks like prudent risk management but it can make a bad situation worse. Cement maker Shanshui, which faces liquidation amid a shareholder spat, is the latest to suffer.
Biotech firm’s stock buyback emits bad bouquet
NantKwest wants to snap up a large chunk of stock at a big discount to its July IPO. Yet the biotech controlled by Patrick Soon-Shiong needs the money as it’s likely to burn cash for years. A buyback would, though, prop up the price ahead of an expiring lockup for executives.
Legal eagles earn a higher corporate pay perch
Compensation for S&P 500 general counsels is up almost 23 pct since 2010, a sharper rise than for CEOs and CFOs. It’s a sign that companies are choosing to handle more big deals, lawsuits and regulatory issues in-house. Outside law firms should brace for a steeper dive in demand.
Apple and banks spoil for electronic-payment fight
JPMorgan, Wells Fargo and others may let customers send money over the iPhone maker’s network. All are playing catch-up to the likes of PayPal and Facebook. The Apple Pay plan may wrest back some control for banks, but also portends an intense battle for money flows.